SoundBite Hearing System Long Term Multi Site Patient Use Study
NCT01445977 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 150
Last updated 2013-08-02
Summary
This study is designed to collect data about the SoundBite™ Hearing System to answer specific questions. The hearing system has been cleared for commercial distribution by the Food and Drug Administration (FDA). Sonitus hopes to learn from a larger group of users what features and settings of this device provide the best hearing ability for people diagnosed with Single Sided Deafness (SSD) or Conductive Hearing Loss (CHL).
Conditions
- Single Sided Deafness
- Conductive Hearing Loss
Sponsors & Collaborators
-
Sonitus Medical Inc
lead INDUSTRY
Principal Investigators
-
Gerald Popelka, PhD · Stanford University
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2011-09-30
- Primary Completion
- 2013-09-30
- Completion
- 2013-09-30
Countries
- United States
Study Locations
More Related Trials
-
The EarLens Contact Hearing Device (CHD) Spectrum Study
NCT02470494 ·Status: COMPLETED ·Phase: NA
-
Hearing Screener Study
NCT05848804 ·Status: UNKNOWN
-
Single-sided Deafness and Cochlear Implantation
NCT05052944 ·Status: COMPLETED
-
Assessment of The Efficacy of Intratympanic Platelet Rich Plasma for Treatment of Sensorineural Hearing Loss.
NCT05786378 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
The Neuro Zti Cochlear Implant System Efficacy and Safety in Adults
NCT02941627 ·Status: COMPLETED ·Phase: NA
-
FX-322 in Adults With Acquired Sensorineural Hearing Loss
NCT05086276 ·Status: COMPLETED ·Phase: PHASE2
-
Pivotal Clinical Trial Evaluating the Safety and Efficacy of the Fully Implanted Acclaim Cochlear Implant
NCT06699797 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
OTO-413 in Subjects With Speech-in-Noise Hearing Impairment
NCT04129775 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
ACEMg Hearing Preservation, Tinnitus and Hyperacusis Relief
NCT06477354 ·Status: COMPLETED ·Phase: NA
-
FX-322 in Sensorineural Hearing Loss
NCT03616223 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
FX-322 in Adults With Severe Sensorineural Hearing Loss
NCT04629664 ·Status: COMPLETED ·Phase: PHASE1
-
A Study Of The Effects Of PF-04958242 In Subjects With Age-Related Hearing Loss
NCT01518920 ·Status: COMPLETED ·Phase: PHASE1
-
Expanded Indications in the MED-EL Pediatric Cochlear Implant Population
NCT03900897 ·Status: COMPLETED ·Phase: NA
-
FX-322 in Adults With Age-Related Sensorineural Hearing Loss
NCT04601909 ·Status: COMPLETED ·Phase: PHASE1
-
Clinical Evaluation of the Cochlear Nucleus CI532 Cochlear Implant in Adults
NCT03007472 ·Status: COMPLETED ·Phase: NA
-
Neuro 1 vs. Neuro 2 Sound Processors
NCT03756337 ·Status: COMPLETED ·Phase: NA
-
Single-Sided Deafness and Asymmetric Hearing Loss
NCT04506853 ·Status: RECRUITING ·Phase: NA
-
CI532 - Early Experience Study
NCT02755935 ·Status: COMPLETED ·Phase: NA
-
Safety and Effectiveness of Cochlear Implantation in an Expanded Adult Population
NCT06293482 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
A Study to Evaluate Clinical Benefit, Performance and Safety of Cochlear Implants in Adults
NCT07338864 ·Status: NOT_YET_RECRUITING
-
Acceptance and Performance of CP1110 Sound Processor With Experienced Adult Cochlear Implant Recipients.
NCT05080283 ·Status: COMPLETED ·Phase: NA
-
First in Human Safety Study of FX-345 in Adults With Sensorineural Hearing Loss
NCT05664100 ·Status: TERMINATED ·Phase: PHASE1
-
Phase I/IIa Study Evaluating Safety and Efficacy of an Intratympanic Dose of PIPE-505 in Subjects With Hearing Loss
NCT04462198 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Antioxidation Medication for Noise-induced Hearing Loss
NCT00552786 ·Status: COMPLETED ·Phase: PHASE2
-
Cochlear Implants in Young Children With SSD
NCT05775367 ·Status: RECRUITING ·Phase: NA